People Briefs

Stryker CFO retires and Osiris Therapeutics CEO resigns, as SpineGuard and Tandem Diabetes Care expand management teams.

Stryker Corp. has appointed Glenn S. Boehnlein VP and chief financial officer, effective April 1, taking over for the retiring William R. Jellison. Boehnlein joined Stryker in 2003 as VP of finance and IT for the company’s endoscopy division and has taken on roles of increasing responsibility. He assumed his latest position as Group CFO of MedSurg & Neurotechnology in 2011. Prior to joining Stryker, Boehnlein was CFO at Success TV Ltd.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business